Edition:
United States

Becton Dickinson and Co (BDX.N)

BDX.N on New York Stock Exchange

222.87USD
16 Feb 2018
Change (% chg)

$0.36 (+0.16%)
Prev Close
$222.51
Open
$221.66
Day's High
$224.83
Day's Low
$221.39
Volume
328,159
Avg. Vol
397,721
52-wk High
$248.20
52-wk Low
$175.75

Chart for

About

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of... (more)

Overall

Beta: 1.18
Market Cap(Mil.): $51,128.12
Shares Outstanding(Mil.): 229.41
Dividend: 0.75
Yield (%): 1.35

Financials

  Industry Sector
P/E (TTM): -- 34.52 17.27
EPS (TTM): -- -- --
ROI: -- 14.12 35.43
ROE: -- 16.75 17.10

BRIEF-Becton Dickinson Files For Offering EUR 300 Mln Add. 0.368% Notes

* BECTON DICKINSON AND CO FILES FOR OFFERING EUR 300 MILLION AGGREGATE PRINCIPAL AMOUNT OF ADDITIONAL 0.368% NOTES DUE 2019 - SEC FILING

Feb 16 2018

BRIEF-Becton Dickinson Says Received Pre-Market Approval From FDA For BD Onclarity HPV Assay

* FDA APPROVES NEW HPV TEST THAT DETECTS AND IDENTIFIES HPV GENOTYPES THAT PUT WOMEN AT HIGH RISK FOR CERVICAL CANCER Source text for Eikon: Further company coverage:

Feb 13 2018

BRIEF-Becton Dickinson Q1 Loss Per Share $0.76

* BD ANNOUNCES RESULTS FOR 2018 FIRST FISCAL QUARTER; PROVIDES FISCAL 2018 GUIDANCE UPDATED FOR INCLUSION OF BARD

Feb 06 2018

BRIEF-BD Statement On FDA Warning Letter For Preanalytical Systems Business Unit

* BD STATEMENT ON FDA WARNING LETTER FOR PREANALYTICAL SYSTEMS BUSINESS UNIT

Jan 12 2018

BRIEF-FDA Issues Warning Letter To Becton Dickinson & Co

* FDA WARNS BECTON DICKINSON & COMPANY OF SIGNIFICANT VIOLATIONS OF THE LAW AS PART OF ONGOING INVESTIGATION INTO LEAD TESTING ISSUES‍​

Jan 11 2018

UPDATE 1-Becton Dickinson's $24 bln takeover of C R Bard set to close after China nod

* Becton had said China approval was last hurdle for deal to close

Dec 28 2017

China commerce ministry conditionally approves Becton Dickinson-C R Bard merger

BEIJING China's commerce ministry said on Thursday that it has conditionally approved a merger between U.S. medical equipment supplier Becton Dickinson and its U.S. peer C R Bard .

Dec 28 2017

China commerce ministry conditionally approves Becton Dickinson-C R Bard merger

BEIJING, Dec 28 China's commerce ministry said on Thursday that it has conditionally approved a merger between U.S. medical equipment supplier Becton Dickinson and its U.S. peer C R Bard.

Dec 28 2017

Becton, Dickinson to divest two product lines for C R Bard buy: FTC

WASHINGTON U.S. medical equipment supplier Becton Dickinson and C R Bard have agreed to divest two product lines to satisfy U.S. Federal Trade Commission concerns their proposed $24 billion merger would negatively affect competition.

Dec 22 2017

UPDATE 1-Becton, Dickinson to divest two product lines for C R Bard buy -FTC

WASHINGTON, Dec 22 U.S. medical equipment supplier Becton Dickinson and C R Bard have agreed to divest two product lines to satisfy U.S. Federal Trade Commission concerns their proposed $24 billion merger would negatively affect competition.

Dec 22 2017

Earnings vs. Estimates